ISET 2022: 90% Reduction in Occluded Pulmonary Arteries with BASHIR™️ Endovascular Catheter

Подробнее о видео

Watch the full video on Radcliffe Vascular here:

In this video interview, Dr Ripal Gandhi (Miami Cardiac and Vascular Institute, Miami, FL, US) presents an interim analysis of the RESCUE study - a prospective multicenter trial evaluating the efficacy and safety of the BASHIR™️ Endovascular Catheter device in patients with pulmonary embolism. Originally presented at the International Symposium on Endovascular Therapy (ISET) 2022, early findings show a 90% reduction in occluded segmental pulmonary arteries with the use of this catheter.

Discussion Points:
1. Importance of this study
2. The BASHIR™️ Endovascular Catheter
3. Key Findings
4. Take-Home Messages
5. Further Study Required

Recorded remotely from Miami, 2022.
Interviewer: Jordan Rance

This content is intended for healthcare professionals only.

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.